Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2010
11/11/2010US20100286213 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
11/11/2010US20100286206 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
11/11/2010US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286195 Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/11/2010US20100286194 Method for treating addiction
11/11/2010US20100286193 Novel Azabicyclo[3.2.1]Oct-2-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
11/11/2010US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators
11/11/2010US20100286188 Means for improving cognitive functions and memory based on hydrogenated pyrido(4,3-b)indoles (variants), pharmacological means based thereon and method for the use thereof
11/11/2010US20100286186 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
11/11/2010US20100286170 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
11/11/2010US20100286165 Substituted oxindole compounds
11/11/2010US20100286164 Substituted aryl alkylamino-oxy-analogs and uses thereof
11/11/2010US20100286161 Pyrazine derivatives and their use as potassium channel modulators
11/11/2010US20100286159 Pyridazines
11/11/2010US20100286149 Novel benzamide derivatives useful as potassium channel modulators
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286145 Isophthalamide derivatives inhibiting beta-secretase activity
11/11/2010US20100286138 Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
11/11/2010US20100286137 Method of Treating Conditions Involving PPAR-Receptors with Indole Compounds
11/11/2010US20100286134 Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/11/2010US20100286132 Pyridines
11/11/2010US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/11/2010US20100286128 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligands
11/11/2010US20100286124 Prop-2-yn-1-amine inhibitors of monoamine oxidase type b
11/11/2010US20100286122 CGRP Antagonist Salt
11/11/2010US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/11/2010US20100286117 Pyridines
11/11/2010US20100286116 Thiazoles
11/11/2010US20100286115 Pyrazoles
11/11/2010US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof
11/11/2010US20100286107 Oligomer-Corticosteroid Conjugates
11/11/2010US20100286095 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
11/11/2010US20100286073 Compounds and methods for pharmaceutical use
11/11/2010US20100286072 Retro-inverso peptides derived from interleukin-6
11/11/2010US20100286063 GNRH agonist combination drugs
11/11/2010US20100286054 Composition
11/11/2010US20100286053 Plasminogen activator inhibitor amelioration of newborn hypoxic ischemic brain injury
11/11/2010US20100286052 Novel use of antisecretory factor
11/11/2010US20100286051 MEMORY AND LEARNING IMPAIRMENTS ASSOCIATED WITH DISRUPTION OF EPHRIN RECEPTOR A6 (EphA6) GENE
11/11/2010US20100286048 Albumin Fusion Proteins
11/11/2010US20100286043 Use of neuregulin-1 in reducing brain damage
11/11/2010US20100286039 Use of SCF and G-CSF in the Treatment of Cerebral Ischemia and Neurological Disorders
11/11/2010US20100286037 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase
11/11/2010US20100286029 Use of a peptide as a therapeutic agent
11/11/2010US20100286021 Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related Disorders
11/11/2010US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
11/11/2010US20100285164 Orally Disintegrating Excipient
11/11/2010US20100285145 Gpr 119 modulators
11/11/2010US20100285127 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives
11/11/2010US20100285124 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological
11/11/2010US20100285119 Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
11/11/2010US20100285113 Enhanced stability of inverse thermal gelling composite hydrogels
11/11/2010US20100285108 Method for therapeutic use
11/11/2010US20100285075 Novel Hemioxalate Salt of Eletriptan
11/11/2010US20100285064 Adjuvant composition for vaccine
11/11/2010US20100285033 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
11/11/2010US20100285031 Hox Compositions and Methods
11/11/2010US20100285016 PRO34128 nucleic acids
11/11/2010US20100285014 Immunoglobulin fusion proteins
11/11/2010US20100285002 Treatment or prevention of inflammation by targeting cyclin d1
11/11/2010US20100284990 Compositions and Methods for Making Therapies Delivered by Viral Vectors Reversible for Safety and Allele-Specificity
11/11/2010US20100284986 Compositions and methods for prevention and treatment of migraines
11/11/2010US20100284984 Adenosine and its mimetics. modulators, transport inhibitors, and receptor agonists as a therapeutic tool to replace or improve the efficacy of deep brain stimulation
11/11/2010US20100284979 Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
11/11/2010US20100284978 Cultures, products and methods using umbilical cord matrix cells
11/11/2010US20100284977 Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
11/11/2010US20100284974 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
11/11/2010US20100284972 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
11/11/2010US20100284960 Dosage Forms and Co-Administration of Opioid Agonist and Opioid Antagonist
11/11/2010US20100284940 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
11/11/2010US20100284926 Use of g-csf for the treatment of stroke
11/11/2010US20100284922 Marker
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
11/11/2010DE202010011306U1 Rezept Dormirell Recipe Dormirell
11/11/2010CA2799157A1 Ammo acid derivatives for the treatment of neuropathic pain
11/11/2010CA2761489A1 High penetration prodrug compositions of peptides and peptide-related compounds
11/11/2010CA2761203A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/11/2010CA2761032A1 Phenoxymethyl heterocyclic compounds
11/11/2010CA2760746A1 Isoxazole-pyrazole derivatives
11/11/2010CA2760166A1 Isoxazole-pyridine derivatives
11/11/2010CA2759598A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
11/11/2010CA2758289A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/11/2010CA2757412A1 Isoxazole-pyridine derivatives as gaba modulators
11/10/2010EP2248887A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application
11/10/2010EP2248817A2 Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/10/2010EP2248816A2 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR ] PYRAZOLO [1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
11/10/2010EP2248815A2 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/10/2010EP2248814A2 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a] PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
11/10/2010EP2248813A1 Production method and production device for composition having high content of theobromine
11/10/2010EP2248811A1 2-oxochromene derivative
11/10/2010EP2248808A1 Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
11/10/2010EP2248801A1 Inhibitors of cytosolic phospholipase a2
11/10/2010EP2248534A1 Botulinum toxin and the treatment of primary disorders of mood and affect
11/10/2010EP2248524A2 Preventives/remedies for stress urinary incontinence and method of screening the same
11/10/2010EP2247599A1 Substituted arylamide oxazepinopyrimidone derivatives
11/10/2010EP2247598A1 Substituted heteroarylamide oxazepinopyrimidone derivatives
11/10/2010EP2247590A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
11/10/2010EP2247589A1 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
1 ... 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 ... 1833